Dr Wu Skincare Co's Days Sales Outstanding for the
three
months ended in Dec. 2025 was 58.42.
Dr Wu Skincare Co's Days Inventory for the
three
months ended in Dec. 2025 was 179.4.
Dr Wu Skincare Co's Days Payable for the
three
months ended in Dec. 2025 was 49.8.
Therefore, Dr Wu Skincare Co's Cash Conversion Cycle (CCC) for the
three
months ended in Dec. 2025 was 188.02.
Dr Wu Skincare Co (ROCO:6523) Cash Conversion Cycle Explanation
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Dr Wu Skincare Co Cash Conversion Cycle Related Terms
Dr Wu Skincare Co Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Dr Wu Skincare Co's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6523 vs PG, CL, KVUE: Cash Conversion Cycle Comparison
For the Household & Personal Products subindustry, Dr Wu Skincare Co's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Wu Skincare Co Cash Conversion Cycle vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Dr Wu Skincare Co's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Dr Wu Skincare Co's Cash Conversion Cycle falls into.
Dr Wu Skincare Co Cash Conversion Cycle Calculation
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Dr Wu Skincare Co's Cash Conversion Cycle for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Wu Skincare Co (ROCO:6523) has a Cash Conversion Cycle of 188.02 as of Dec. 2025. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Dr Wu Skincare Co and its competitors.
Is Dr Wu Skincare Co's Cash Conversion Cycle too high?
Dr Wu Skincare Co's current Cash Conversion Cycle is 188.02. The Consumer Packaged Goods industry median Cash Conversion Cycle is 75.52. Dr Wu Skincare Co's value of 188.02 is 149% above this industry median. Overall, Dr Wu Skincare Co has a GF Score™ of 81/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Wu Skincare Co's Cash Conversion Cycle compare to PG and CL?
Dr Wu Skincare Co's Cash Conversion Cycle of 188.02 can be compared against companies in the Consumer Packaged Goods industry. The industry median Cash Conversion Cycle is 75.52. Dr Wu Skincare Co's value of 188.02 is 149% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Consumer Packaged Goods company?
The median Cash Conversion Cycle among Consumer Packaged Goods companies is 75.52, based on 1,941 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Wu Skincare Co's current Cash Conversion Cycle of 188.02 is 149% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Dr Wu Skincare Co and its competitors. For the Consumer Packaged Goods industry, the median Cash Conversion Cycle is 75.52 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Wu Skincare Co's current Cash Conversion Cycle is 188.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Wu Skincare Co stock overvalued right now?
Based on GuruFocus' analysis, Dr Wu Skincare Co (ROCO:6523) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$151.63, compared to a current price of NT$91.00 — trading 40% below its estimated fair value. The current Cash Conversion Cycle is 188.02 and 149% above the Consumer Packaged Goods industry median of 75.52. Dr Wu Skincare Co's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Dr Wu Skincare Co (ROCO:6523), the current Cash Conversion Cycle is 188.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Wu Skincare Co (ROCO:6523) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Wu Skincare Co stock appears to be undervalued.
The current stock price of NT$91.00 is trading 40% below its estimated GF Value™ of NT$151.63.
GuruFocus considers Dr Wu Skincare Co to be Significantly Undervalued.
Key valuation signals for ROCO:6523:
Cash Conversion Cycle: 188.02
GF Value™: NT$151.63 vs. price of NT$91.00 (40% below fair value)
Industry Position: 149% above the Consumer Packaged Goods median
No single metric tells the full story. See the ROCO:6523 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Wu Skincare Co Ltd is a Taiwan based company engaged in the research, development, production, wholesale and retail of cosmetics. It principally manufactures and sells cosmetics. The company offers products such as cosmetic masks, lotions, eye care products, moisturizers and others. The group derives its revenue from the sales of private label care products. It sells the products in Taiwan and internationally, of which majority of the revenue is derived from the sales made in Taiwan.
81GF Score
Get the complete analysis for ROCO:6523
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6523 has been successfully added to your 
